Cargando…

Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches

Over the past decades the food industry has been revolutionized toward the production of functional foods due to an increasing awareness of the consumers on the positive role of food in wellbeing and health. By definition probiotic foods must contain live microorganisms in adequate amounts so as to...

Descripción completa

Detalles Bibliográficos
Autores principales: Papadimitriou, Konstantinos, Zoumpopoulou, Georgia, Foligné, Benoit, Alexandraki, Voula, Kazou, Maria, Pot, Bruno, Tsakalidou, Effie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330916/
https://www.ncbi.nlm.nih.gov/pubmed/25741323
http://dx.doi.org/10.3389/fmicb.2015.00058
_version_ 1782357647061680128
author Papadimitriou, Konstantinos
Zoumpopoulou, Georgia
Foligné, Benoit
Alexandraki, Voula
Kazou, Maria
Pot, Bruno
Tsakalidou, Effie
author_facet Papadimitriou, Konstantinos
Zoumpopoulou, Georgia
Foligné, Benoit
Alexandraki, Voula
Kazou, Maria
Pot, Bruno
Tsakalidou, Effie
author_sort Papadimitriou, Konstantinos
collection PubMed
description Over the past decades the food industry has been revolutionized toward the production of functional foods due to an increasing awareness of the consumers on the positive role of food in wellbeing and health. By definition probiotic foods must contain live microorganisms in adequate amounts so as to be beneficial for the consumer’s health. There are numerous probiotic foods marketed today and many probiotic strains are commercially available. However, the question that arises is how to determine the real probiotic potential of microorganisms. This is becoming increasingly important, as even a superficial search of the relevant literature reveals that the number of proclaimed probiotics is growing fast. While the vast majority of probiotic microorganisms are food-related or commensal bacteria that are often regarded as safe, probiotics from other sources are increasingly being reported raising possible regulatory and safety issues. Potential probiotics are selected after in vitro or in vivo assays by evaluating simple traits such as resistance to the acidic conditions of the stomach or bile resistance, or by assessing their impact on complicated host functions such as immune development, metabolic function or gut–brain interaction. While final human clinical trials are considered mandatory for communicating health benefits, rather few strains with positive studies have been able to convince legal authorities with these health claims. Consequently, concern has been raised about the validity of the workflows currently used to characterize probiotics. In this review we will present an overview of the most common assays employed in screening for probiotics, highlighting the potential strengths and limitations of these approaches. Furthermore, we will focus on how the advent of omics technologies has reshaped our understanding of the biology of probiotics, allowing the exploration of novel routes for screening and studying such microorganisms.
format Online
Article
Text
id pubmed-4330916
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-43309162015-03-04 Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches Papadimitriou, Konstantinos Zoumpopoulou, Georgia Foligné, Benoit Alexandraki, Voula Kazou, Maria Pot, Bruno Tsakalidou, Effie Front Microbiol Microbiology Over the past decades the food industry has been revolutionized toward the production of functional foods due to an increasing awareness of the consumers on the positive role of food in wellbeing and health. By definition probiotic foods must contain live microorganisms in adequate amounts so as to be beneficial for the consumer’s health. There are numerous probiotic foods marketed today and many probiotic strains are commercially available. However, the question that arises is how to determine the real probiotic potential of microorganisms. This is becoming increasingly important, as even a superficial search of the relevant literature reveals that the number of proclaimed probiotics is growing fast. While the vast majority of probiotic microorganisms are food-related or commensal bacteria that are often regarded as safe, probiotics from other sources are increasingly being reported raising possible regulatory and safety issues. Potential probiotics are selected after in vitro or in vivo assays by evaluating simple traits such as resistance to the acidic conditions of the stomach or bile resistance, or by assessing their impact on complicated host functions such as immune development, metabolic function or gut–brain interaction. While final human clinical trials are considered mandatory for communicating health benefits, rather few strains with positive studies have been able to convince legal authorities with these health claims. Consequently, concern has been raised about the validity of the workflows currently used to characterize probiotics. In this review we will present an overview of the most common assays employed in screening for probiotics, highlighting the potential strengths and limitations of these approaches. Furthermore, we will focus on how the advent of omics technologies has reshaped our understanding of the biology of probiotics, allowing the exploration of novel routes for screening and studying such microorganisms. Frontiers Media S.A. 2015-02-17 /pmc/articles/PMC4330916/ /pubmed/25741323 http://dx.doi.org/10.3389/fmicb.2015.00058 Text en Copyright © 2015 Papadimitriou, Zoumpopoulou, Foligné, Alexandraki, Kazou, Pot and Tsakalidou. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Papadimitriou, Konstantinos
Zoumpopoulou, Georgia
Foligné, Benoit
Alexandraki, Voula
Kazou, Maria
Pot, Bruno
Tsakalidou, Effie
Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches
title Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches
title_full Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches
title_fullStr Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches
title_full_unstemmed Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches
title_short Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches
title_sort discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330916/
https://www.ncbi.nlm.nih.gov/pubmed/25741323
http://dx.doi.org/10.3389/fmicb.2015.00058
work_keys_str_mv AT papadimitrioukonstantinos discoveringprobioticmicroorganismsinvitroinvivogeneticandomicsapproaches
AT zoumpopoulougeorgia discoveringprobioticmicroorganismsinvitroinvivogeneticandomicsapproaches
AT folignebenoit discoveringprobioticmicroorganismsinvitroinvivogeneticandomicsapproaches
AT alexandrakivoula discoveringprobioticmicroorganismsinvitroinvivogeneticandomicsapproaches
AT kazoumaria discoveringprobioticmicroorganismsinvitroinvivogeneticandomicsapproaches
AT potbruno discoveringprobioticmicroorganismsinvitroinvivogeneticandomicsapproaches
AT tsakalidoueffie discoveringprobioticmicroorganismsinvitroinvivogeneticandomicsapproaches